DE69632827D1 - Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen - Google Patents

Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen

Info

Publication number
DE69632827D1
DE69632827D1 DE69632827T DE69632827T DE69632827D1 DE 69632827 D1 DE69632827 D1 DE 69632827D1 DE 69632827 T DE69632827 T DE 69632827T DE 69632827 T DE69632827 T DE 69632827T DE 69632827 D1 DE69632827 D1 DE 69632827D1
Authority
DE
Germany
Prior art keywords
methods
presentation
substances
binding
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69632827T
Other languages
English (en)
Other versions
DE69632827T2 (de
Inventor
Lothar Steidler
Erik Remaut
Jeremy Mark Wells
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intrexon Actobiotics NV
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE69632827D1 publication Critical patent/DE69632827D1/de
Publication of DE69632827T2 publication Critical patent/DE69632827T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/746—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for lactic acid bacteria (Streptococcus; Lactococcus; Lactobacillus; Pediococcus; Enterococcus; Leuconostoc; Propionibacterium; Bifidobacterium; Sporolactobacillus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/035—Fusion polypeptide containing a localisation/targetting motif containing a signal for targeting to the external surface of a cell, e.g. to the outer membrane of Gram negative bacteria, GPI- anchored eukaryote proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/22—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a Strep-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mirrors, Picture Frames, Photograph Stands, And Related Fastening Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Adhesive Tapes (AREA)
  • Sheet Holders (AREA)
  • Details Of Rigid Or Semi-Rigid Containers (AREA)
  • Vehicle Interior And Exterior Ornaments, Soundproofing, And Insulation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE69632827T 1995-09-07 1996-09-06 Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen Expired - Lifetime DE69632827T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9518323.2A GB9518323D0 (en) 1995-09-07 1995-09-07 Materials and methods relating to the attachment and display of substances on cell surfaces
GB9518323 1995-09-07
PCT/GB1996/002195 WO1997009437A1 (en) 1995-09-07 1996-09-06 Materials and methods relating to the attachment and display of substances on cell surfaces

Publications (2)

Publication Number Publication Date
DE69632827D1 true DE69632827D1 (de) 2004-08-05
DE69632827T2 DE69632827T2 (de) 2005-07-07

Family

ID=10780370

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69632827T Expired - Lifetime DE69632827T2 (de) 1995-09-07 1996-09-06 Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen

Country Status (17)

Country Link
US (1) US6190662B1 (de)
EP (1) EP0848756B1 (de)
JP (1) JP4180111B2 (de)
KR (1) KR19990044528A (de)
CN (1) CN1201493A (de)
AT (1) ATE270337T1 (de)
AU (1) AU729449B2 (de)
BR (1) BR9610133A (de)
CA (1) CA2231372A1 (de)
DE (1) DE69632827T2 (de)
GB (1) GB9518323D0 (de)
HK (1) HK1014337A1 (de)
MX (1) MX9801864A (de)
NO (1) NO980976L (de)
NZ (1) NZ316580A (de)
WO (1) WO1997009437A1 (de)
ZA (1) ZA967562B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5821088A (en) * 1990-05-11 1998-10-13 Siga Pharmaceuticals, Inc. Use of gram-positive bacteria to express recombinant proteins
GB9521568D0 (en) * 1995-10-20 1995-12-20 Lynxvale Ltd Delivery of biologically active polypeptides
DE19735105A1 (de) * 1997-08-13 1999-03-04 Univ Albert Ludwigs Freiburg Transportsystem zur Einbringung von Proteinen in Zielzellen mit Hilfe eines Fusionsproteins, Nucleinsäurekonstrukte kodierend für die Komponenten des Transportsystems und Arzneimittel, die Komponenten des Transportsystems umfassen
EP0916726A1 (de) * 1997-11-13 1999-05-19 Rijksuniversiteit te Groningen Befestigungs-Substanzen an Mikroorganismen
US6100388A (en) * 1998-03-16 2000-08-08 Biogaia Biologies Ab Lactobacilli harboring aggregation gene as a vaccine delivery vehicle
EP1012245A1 (de) * 1998-06-25 2000-06-28 Korea Green Cross Corporation Oberflächenexpressionssystem von hepatitis b virus oberflächenantigen und kernantigen von hepatitis c virus unter verwendung von eis-kern protein
KR100313135B1 (ko) 1999-02-22 2001-11-05 윤덕용 세포 표면 발현 모체로서의 대장균 유래 세포외막 단백질 ｃ(ｏ
US7220418B1 (en) 1999-07-05 2007-05-22 Vlaams Interuniversitair Instituut Voor Biotechnologie Delivery of trefoil peptides
KR20030034178A (ko) 2000-09-25 2003-05-01 소시에떼 데 프로듀이 네슬레 소시에떼아노님 알레르기 반응을 발달시키는 개인의 경향을 감소시킬 수있는 젖산 박테리아
EP1343894A4 (de) * 2000-11-02 2005-05-04 Univ Singapore Aopb-gen, -protein, homologe, fragmente und varianten davon und ihre verwendung bei der zelloberflächenpräsentation
EP1239032A1 (de) 2001-03-02 2002-09-11 Société des Produits Nestlé S.A. Milchsäurebakterien als Mitteln zur Behandlung und Vorbeugung von Allergie
US7780961B2 (en) * 2001-05-03 2010-08-24 Actogenix N.V. Self-containing Lactococcus strain
JP2005529622A (ja) * 2002-06-19 2005-10-06 ヴェーイーベー・ヴェーゼットウェー 腸吸収を促進するための方法および手段
US7527966B2 (en) * 2002-06-26 2009-05-05 Transgenrx, Inc. Gene regulation in transgenic animals using a transposon-based vector
CA2505326A1 (en) 2002-11-08 2004-05-21 Ablynx N.V. Camelidae antibodies against immunoglobulin e and use thereof for the treatment of allergic disorders
EP1558645B1 (de) 2002-11-08 2011-07-27 Ablynx N.V. Stabilisierte einzel-domänen-antikörper in einer pharmazeutischen zusammensetzung ausgestaltet für inhalation
AU2003298291A1 (en) * 2002-11-15 2004-06-15 Universiteit Gent Self-containing lactobacillus strain
JP2007503845A (ja) * 2003-01-29 2007-03-01 オセル， インコーポレイテッド 細菌における生物学的に活性なタンパク質の表面発現
EP1664784A1 (de) * 2003-09-17 2006-06-07 Guava Technologies, Inc. Zusammensetzungen und verfahren zur analyse von zielsubstanzen
US7456011B2 (en) * 2005-01-12 2008-11-25 Osel, Inc. Modified cyanovirin-n polypeptide
DK2119450T3 (da) 2005-11-29 2013-05-06 Actogenix Nv Induktion af mucosal tolerance over for pankreatisk ø-beta-celle-autoantigener
ES2492468T3 (es) 2007-01-25 2014-09-09 Actogenix N.V. Tratamiento de enfermedad inmunitaria por administración a través de la mucosa de antígenos usando Lactobacillus genéticamente modificado
EP1972350A1 (de) * 2007-03-20 2008-09-24 Rijksuniversiteit Groningen Duales Targeting-System
US20110189236A1 (en) * 2008-05-08 2011-08-04 Emory University Methods and Compositions for the Display of Polypeptides on the Pili of Gram-Positive Bacteria
EP3181682B1 (de) * 2008-09-29 2021-04-21 Intrexon Actobiotics NV Reduzierte mikrobenkolonisierung an der schleimhaut
WO2014039746A1 (en) 2012-09-07 2014-03-13 Emory University Hiv immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto
WO2014047625A1 (en) 2012-09-24 2014-03-27 Montana State University Recombinant lactococcus lactis expressing escherichia coli colonization factor antigen i (cfa/i) fimbriae and their methods of use
WO2022140640A1 (en) * 2020-12-23 2022-06-30 Chan Zuckerberg Biohub, Inc. Bacteria-engineered to elicit antigen-specific t cells

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5616686A (en) 1990-05-11 1997-04-01 The Rockefeller University Polypeptide of a hybrid surface protein by bacteria
US5348867A (en) * 1991-11-15 1994-09-20 George Georgiou Expression of proteins on bacterial surface
JP3626181B2 (ja) * 1992-03-13 2005-03-02 ザ ロックフェラー ユニバーシティー グラム陽性菌の表面上のハイブリッド表面タンパク質の供給及び発現

Also Published As

Publication number Publication date
BR9610133A (pt) 1999-12-21
CN1201493A (zh) 1998-12-09
DE69632827T2 (de) 2005-07-07
HK1014337A1 (en) 1999-09-24
NO980976L (no) 1998-05-06
AU729449B2 (en) 2001-02-01
MX9801864A (es) 1998-11-29
NO980976D0 (no) 1998-03-06
EP0848756B1 (de) 2004-06-30
ZA967562B (en) 1998-03-06
JP4180111B2 (ja) 2008-11-12
KR19990044528A (ko) 1999-06-25
US6190662B1 (en) 2001-02-20
JPH11511983A (ja) 1999-10-19
NZ316580A (en) 1999-09-29
WO1997009437A1 (en) 1997-03-13
CA2231372A1 (en) 1997-03-13
GB9518323D0 (en) 1995-11-08
AU6884496A (en) 1997-03-27
EP0848756A1 (de) 1998-06-24
ATE270337T1 (de) 2004-07-15

Similar Documents

Publication Publication Date Title
DE69632827D1 (de) Materialen und methoden im zusammenhang mit bindung und präsentation von substanzen auf zelloberflächen
ATE353906T1 (de) Cd27 ligand
ATE184052T1 (de) Gdf-1 und uog1 proteine
FI943389A0 (fi) Bacillus-lajista saatu ksylanaasi, tällaisen ksylanaasin ja muiden proteiinien ekspressiovektori, niiden isäntäorganismit ja käyttö
AU2894289A (en) Domain-modified constant region antibodies
DK1042461T3 (da) Ekspressionskloning i filiforme svampe
TR199900666T2 (xx) �nsan paratormonu ile ilgili peptidlere kar�� antikor.
DK0807178T3 (da) Mycobaktielle proteiner, mikroorganismer producerende samme og anvendelser af nævnte proteiner i vacciner og til påvisning af tuberkulose
NO971875D0 (no) Cathepsin 02 protease
CA2166691A1 (en) Bacillus thuringiensis transposon tn5401 and its use in a site-specific recombination system for bacillus thuringiensis strain development
CA2160131A1 (en) New Bacillus Thuringiensis Strains and Their Insecticidal Proteins
BR9607583B1 (pt) plasmìdios procarióticos recombinantes.
FI972457A (fi) FAS/APO1-reseptorien toiminnan modulaattorit
AU8812498A (en) Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
EP1798287A3 (de) Membranproteine aus Säugetierzellen und verwandte Reagentien
PT1025245E (pt) Criacao rapida de linhas celulares estaveis de mamifero produzindo elevados iiveis de proteinas recombinantes
ATE285474T1 (de) Haemophilus adhäsionsproteinen
HUP9900750A2 (hu) Gén kifejezésére szolgáló promóterek
BR9101587A (pt) Processo para obtencao de proteinas de fusao;estrutura de gene;vetor;celula de estreptomiceto;proteina de fusao;e utilizacao da ultima
DK0745122T3 (da) Galninreceptor, nukleinsyrer, transformerede celler og anvendelser heraf
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
DK0533701T3 (da) Færgevektor til udvikling af rekombinant Bacillus thuringiensis stamme
CA2199403A1 (en) Novel PKA-Binding Proteins and Uses Thereof
DE59108261D1 (de) Peptide des HIV-gag Proteins, ihre Herstellung und Verwendung
CA2199843A1 (en) Novel PKA-Binding Proteins and Uses Thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ACTOGENIX NV, ZWIJNAARDE, BE

8381 Inventor (new situation)

Inventor name: STEIDLER, LOTHAR, 9000 GENT, BE

Inventor name: REMAUT, ERIK, 9000 GENT, BE

Inventor name: WELLS, MARK, JEREMY, CAMBRIDGE CB2 1QP, GB